secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001493152-24-020222
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director David LaPre resigns from Calidi Biotherapeutics board
--------------------------------------------------------------

- David LaPre resigned as director and from all board committees effective May 10, 2024.
- Resignation not due to any dispute with the company or Board on operations or policies.
- No replacement director has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224020222/0001493152-24-020222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224020222/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer